The blood glucose monitoring system market involves devices and technologies designed to help individuals, particularly those with diabetes, measure and manage their blood sugar levels effectively. It includes traditional self-monitoring blood glucose (SMBG) devices such as glucometers, test strips, and lancets, as well as advanced continuous glucose monitoring (CGM) systems that provide real-time glucose readings and trend analysis. Market growth is driven by the rising global prevalence of diabetes, increasing awareness about glucose control, and growing adoption of smart, connected monitoring devices. Innovations such as non-invasive sensors, smartphone integration, wearable CGMs, and cloud-based data tracking are transforming diabetes management by enhancing accuracy and user convenience.
According to Fortune Business Insights, the blood glucose monitoring system market share was valued at USD 17.20 billion in 2024 and is projected to grow from USD 18.03 billion in 2025 to USD 27.73 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period. North America dominated the market, accounting for a 44.01% share in 2024.
The Blood Glucose Monitoring System Market report covers a comprehensive analysis of market dynamics, including size, share, trends, growth factors, and future projections up to 2032. It evaluates major segments such as device type, modality, patient type, and distribution channels. The report also provides a detailed competitive landscape and regional insights to help stakeholders make informed strategic decisions.
These leading companies are focusing on product innovation, digital integration, and global market expansion. In April 2025, for example, Dexcom, Inc. received U.S. FDA approval for its Dexcom G7 15-Day CGM device for adults aged 18 and above, strengthening its competitive presence in the market.